Advertisement

DART Therapeutics isn’t your ordinary therapeutics business. The Cambridge therapeutics startup focused on treatments for Duchenne muscular dystrophy(DMD), a fatal neuromuscular disorder with no current treatment affecting one in 3,500 boys worldwide, has made several new executive appointments to its leadership team.

Advertisement
Advertisement